Ambulatory infusion centers provide convenient outpatient care for those requiring long-term intravenous therapy or infusions. These centers offer various advantages over traditional hospital-based infusion therapy such as lower costs, flexibility in scheduling, and a more comfortable environment. The need for ambulatory infusion centers is growing due to the rise in chronic diseases like cancer, diabetes, and cardiovascular conditions that often require IV medication. These centers allow patients to receive treatment while continuing their daily activities and routines.
The global Ambulatory Infusion Center Market is estimated to be valued at US$ 60883.85 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The ambulatory infusion center market is expected to witness significant growth over the forecast period owing to rising prevalence of chronic diseases. According to the Center for Disease Control and Prevention (CDC), around 6 in 10 adults in the U.S. suffer from a chronic disease. Growing geriatric population is another major factor fueling demand for ambulatory infusion centers. People aged 65 years and above are more susceptible to chronic diseases due to decreased immune function with age. Furthermore, technological advancements in infusion therapy and increasing adoption of specialty drug infusion are also driving market growth. However, high setup and maintenance costs associated with ambulatory infusion centers may hamper market expansion to some extent.
Porter’s Analysis
Threat of new entrants: Low. Significant initial capital investment and regulatory barriers restrict entry.
Bargaining power of buyers: High. Presence of large healthcare providers puts pricing pressure on suppliers.
Bargaining power of suppliers: Low. Market dominated by few large players reducing supplier bargaining power.
Threat of new substitutes: Low. Limited substitutes for specialized ambulatory infusion center offerings.
Competitive rivalry: High. Intense competition between existing players to gain market share.
Key Takeaways
The Global Ambulatory Infusion Center Market Growth is expected to witness high.
Regional analysis: North America dominates the ambulatory infusion center market and is expected to continue its dominance over the forecast period owing to the increasing prevalence of chronic diseases and presence of advanced healthcare infrastructure in the region.
Key players operating in the Ambulatory Infusion Center Market are Johnson & Johnson (DePuy Synthes), Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings, Inc. Key players are focusing on new product launches and mergers & acquisitions to strengthen their market position.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it